LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis.
about
UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization.Emodin and rhein decrease levels of hypoxia-inducible factor-1α in human pancreatic cancer cells and attenuate cancer cachexia in athymic mice carrying these cells.Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge.
P2860
LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@en
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@nl
type
label
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@en
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@nl
prefLabel
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@en
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@nl
P2093
P2860
P356
P1433
P1476
LY6E: a conductor of malignant ...... the PTEN/PI3K/Akt/HIF-1 axis.
@en
P2093
Akiyo Morinibu
Chan Joo Yeom
Cheol-Goo Hur
Ester M Hammond
Hiroshi Harada
Kazumi Shinomiya
Lihua Zeng
Masahiro Hiraoka
Michio Yoshimura
Minoru Kobayashi
P2860
P304
65837-65848
P356
10.18632/ONCOTARGET.11670
P407
P577
2016-08-29T00:00:00Z